Rhone Poulenc Rorer, a subsidiary of Solvay SA, is a French company that manufactures and distributs pharmaceutical products.

Since the establishment of Sunkyung Textiles in 1969, SK Chemicals has grown through continuous change and innovation into a chemical and life sciences enterprise representing South Korea. SK Chemicals’ new mission statement says, "They enhance human health and protect the Earth’s environment" and they have reorganized their business structure to focus on the two large sectors of green chemicals and life sciences. Providing distinguished chemical and life sciences products and solutions based on the world's highest technology standards, SK Chemicals is recognized as a leading global company of environmentally-friendly materials and total healthcare solutions. Their green chemical business is steadily progressing as a leading global company in the environmentally-friendly materials business by using the world’s best technology, knowledge, and production facilities. To achieve this goal, SK Chemicals has selected four new core areas of business: bio-materials, composites, high-performance materials, and energy saving materials while continuing a commitment to R&D activities.

Part of Sanofi, Aventis Pharma SARL is a French company located in Antony. The firm manufactures pharmaceuticals. It was founded in 1982.

was founded in 2013 to develop novel compounds that are effective on both drug-resistant tumors and cancer stem cells. In numerous preclinical models of cancer, including colon, pancreatic, prostate, breast and lung cancers the company’s lead product SBT-1214 has shown to completely eliminate the tumor. Additional studies have shown that SBT-1214 is able to effectively down-regulate “stemness” gene expression and kill cancer stem cells. Additional chemical modifications and a novel fatty-acid based nanoemulsion formulation result in a drug that has improved pharmacokinetics and pharmacodynamics properties as well as reduced toxicity.

Aphios Corp. is a private company headquartered in Woburn, MA, with domestic subsidiaries. The firm develops technology platforms for drug discovery, delivery and safety. It was founded in 1993 by Trevor P. Castor, who has been the CEO since the inception date.\nThe company says this about itself: Aphios Corporation is a clinical stage biotechnology company developing enabling technology platforms for improving drug discovery, manufacturing, delivery and safety, and enhanced therapeutics for the treatment of cancers and supportive care, infectious diseases such as HIV, and CNS disorders such as Alzheimer’s disease.

SD Pharmaceuticals, Inc., a subsidiary of Savara, Inc., is an American company located in Carlsbad, CA, focused on pharmaceutical preparations. The firm was founded by Andrew Xian Chen. On April 28, 2006 Mast Therapeutics, Inc. acquired SD Pharmaceuticals, Inc. for $9.89 million.

Cadila Pharmaceuticals Ltd. manufactures and distributes pharmaceutical products. The company is involved in manufacturing pharmaceutical products, new drug discovery, novel drug delivery, analytical research, biosynthesis and genetic engineering. It also manufactures cardiovascular, gastrointestinal, anti inflammatory, antibiotics, vaccines, anti-diabetic and vitamin drugs. The company was founded in 1951 by Indravadan Ambalal Modi and is headquartered in Ahmedabad, India.

Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines to treat patients with serious or life-threatening medical conditions. It creates multiple products on the market and a development pipeline. The company became a member of the Roche Group in 2009. As part of their merger agreement, Roche and Genentech combined their pharmaceutical operations in the United States. Genentech’s South San Francisco campus now serves as the headquarters for Roche pharmaceutical operations in the United States. Genentech’s Research and Early Development section operates as an independent center within Roche. Genentech was founded in 1976 by [Robert Swanson](https://www.crunchbase.com/person/robert-a-swanson) and [Herbert Boyer](https://www.crunchbase.com/person/herbert-w-boyer). It is headquartered in South San Francisco, C.A.

Enzon Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to the development, manufacturing, and commercialization of important medicines for patients with cancer and other life-threatening conditions. Enzon has a portfolio of four marketed products, ONCASPAR®, DEPOCYT®, ABELCET® and ADAGEN®. The Company's drug development programs utilize several cutting-edge approaches, including its industry-leading PEGylation technology platform used to create product candidates with benefits such as reduced dosing frequency and less toxicity. Enzon's PEGylation technology was used to develop two of its products, ONCASPAR and ADAGEN, and has created a royalty revenue stream from licensing partnerships for other products developed using the technology. Enzon also engages in contract manufacturing for several pharmaceutical companies to broaden the Company's revenue base.

Ensuiko Sugar Refining Co., Ltd. engages in the manufacture and sale of refined sugar. It operates through the following segments: Sugar, Bio, and Others. The Sugar segment deals with the production and sale of sugar products such as granulite sugar, white sugar, and liquid sugar. The Bio segment handles the manufacture and sale of lactose and fructose oligosaccharides and cyclodextrins. The Others segment manages the leasing of a portion of the company building to third parties. The company was founded in February 1904 and is headquartered in Tokyo, Japan.

Mylan Pharmaceuticals, Inc. develops and manufactures generic prescription products. Its product includes tablets, Fosamax, Sectral, Xanax, capsules, liquids, and transdermal patches. The company was founded in 1961 and is headquartered in Morgantown, WV.

HEXAL is the German generic manufacturer and belongs to the worldwide Sandoz Group with its headquarters in Holzkirchen, Bavaria. HEXAL brings biosimilars to the German market. Biosimilars are high-differentiated products, based on very complex biological molecules. Biologics, or biopharmaceuticals, are medicines produced from living organisms using biotechnology techniques. Many biologics are recombinant proteins and are manufactured using „recombinant DNA“ technology, a process that involves inserting a specific gene into a host cell to produce a particular protein. These complex state-of-the-art molecules represent a distinct regulatory class of medicine compared to traditional, chemically synthesized medicines. In Germany HEXAL employs more then 4.000 people at six sites. The company was founded in 1986 and merged with Sandoz in 2006.

Yung Shin Pharmaceutical Industrial Co., Ltd. engages in the manufacture and sale of pharmaceutical products. Its products include active pharmaceutical ingredients, traditional Chinese medicine, human medicine, animal medicine, food products, and medical equipment. The company was founded by Tien Te Li in 1952 and is headquartered in Taichung, Taiwan.

Pitney Pharmaceuticals Pty Ltd., part of PharmAust Ltd., is a company headquartered in Kogarah, Australia, that provides medical and pharmaceutical services. Richard Mollard is the current CEO of the firm. Pitney Pharmaceuticals Pty Ltd. was acquired by PharmAust Ltd. on August 13, 2013 for $8.18 million.

Aventis Pharmaceuticals is a pharmaceutical company manufacturing drugs for a variety of diseases and disorders. The company is based in India and manufactures drugs for cardiovascular, thrombotic, metabolic disorders, oncology and disorders of the nervous system. The company was the world’s first pharmaceutical company to market an insulin drug for daily use.   The company was founded in 1956 as Hoechst Fedco Pharma. The company is now part of the Sanofi-Aventis group.

Aicuris Anti-Infective Cures AG is a German company located in Wuppertal that engages in research and development in natural sciences, engineering, agricultural sciences and medicines. It was founded in 2006 by Helga R��bsamen-Schaeff. Holger Zimmermann is currently the CEO of the firm.

AiCuris is a clinical-stage biopharmaceutical company focused on resistance breaking antiviral and antibacterial therapeutics targeting Human Cytomegalovirus, Herpes simplex, HIV, Hepatitis B and C and multi-resistant bacteria. AiCuris‘ mission is the development of innovative drugs against severe and life-threatening infectious diseases with high medical need. AiCuris aims to be THE successful innovator for antiviral and antibacterial therapy.

Newsouth Innovations Pty Ltd., a subsidiary of The University of New South Wales, is an Australian company located in Sydney. The firm provides support services for university of new south wales inventors turn their discoveries into innovations. It was founded in 1959. Kevin Cullen is the CEO, in this role since 2011.